Literature DB >> 9371574

Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy.

S Ghazizadeh1, J M Carroll, L B Taichman.   

Abstract

Retrovirus-mediated gene transfer is commonly used in gene therapy protocols and has the potential to provide long-term expression of the transgene. Although expression of a retrovirus-delivered transgene is satisfactory in cultured cells, it has been difficult to achieve consistent and high-level expression in vivo. In this investigation, we explored the possibility of modulating transgene expression by host-derived cytokines. Normal human keratinocytes and dermal fibroblasts were transduced with recombinant retroviruses expressing a reporter gene (lacZ). Treatment of transduced cells with a proinflammatory cytokine, gamma interferon (IFN-gamma), significantly reduced lacZ expression to less than 25% of that of nontreated cells. The inhibition was concentration dependent (peak at 5 ng/ml) and time dependent (maximal at 16 h for transcript and 24 h for protein); expression remained repressed in the continued presence of IFN-gamma but returned to normal levels 24 h after IFN-gamma withdrawal. The decrease in beta-galactosidase activity appeared to result from decrease in steady-state lacZ mRNA levels. Inhibitors of transcription and translation blocked IFN-gamma-induced repression, suggesting involvement of newly synthesized protein intermediates. Similar results were obtained by treatment of transduced cells with IFN-alpha but not with other proinflammatory cytokines, including tumor necrosis factor alpha, interleukin-2 (IL-1), IL-4, and granulocyte colony-stimulating factor. Although the level of lacZ mRNA was reduced by >70% following IFN treatment, the rate of lacZ transcription was not significantly different from that for nontreated cells. These results suggest that IFN-mediated regulation of transgene expression is at a posttranscriptional level. Interestingly, IFN-gamma also suppressed transgene expression driven by a cellular promoter (involucrin) inserted in an internal position in the retroviral vector. The presence of the overlapping 3' untranslated regions in transcripts initiated from the internal promoter and the long terminal repeat is suggestive of a posttranscriptional regulation, likely at the level of RNA stabilization. These results provide direct evidence for modulatory effects of IFNs on retrovirus-mediated transgene expression and suggest that gene therapy results may be altered by host inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371574      PMCID: PMC230218     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Retroviral marking identifies grafted autologous keratinocytes in porcine wounds receiving cultured epithelium.

Authors:  R L Ng; B Woodward; S Bevan; C Green; R Martin
Journal:  J Invest Dermatol       Date:  1997-04       Impact factor: 8.551

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism.

Authors:  M Emerman; H M Temin
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

4.  The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia.

Authors:  Y J Wu; L M Parker; N E Binder; M A Beckett; J H Sinard; C T Griffiths; J G Rheinwald
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

5.  Synthesis of (2'-5')oligoadenylate and activation of an endoribonuclease in interferon-treated HeLa cells infected with reovirus.

Authors:  T W Nilsen; P A Maroney; C Baglioni
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

6.  Antiviral effects of recombinant tumour necrosis factor in vitro.

Authors:  J Mestan; W Digel; S Mittnacht; H Hillen; D Blohm; A Möller; H Jacobsen; H Kirchner
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

7.  Gene expression from transcriptionally disabled retroviral vectors.

Authors:  J K Yee; J C Moores; D J Jolly; J A Wolff; J G Respess; T Friedmann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  Canine model for gene therapy: inefficient gene expression in dogs reconstituted with autologous marrow infected with retroviral vectors.

Authors:  R B Stead; W W Kwok; R Storb; A D Miller
Journal:  Blood       Date:  1988-03       Impact factor: 22.113

9.  Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro.

Authors:  T Collins; L A Lapierre; W Fiers; J L Strominger; J S Pober
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

10.  Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells.

Authors:  J G Rheinwald; H Green
Journal:  Cell       Date:  1975-11       Impact factor: 41.582

View more
  10 in total

1.  Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9.

Authors:  Andreas Pichlmair; Sandra S Diebold; Stephen Gschmeissner; Yasuhiro Takeuchi; Yasuhiro Ikeda; Mary K Collins; Caetano Reis e Sousa
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

2.  High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments.

Authors:  K E Pollok; H Hanenberg; T W Noblitt; W L Schroeder; I Kato; D Emanuel; D A Williams
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

3.  Trichostatin A up-regulates human papillomavirus type 11 upstream regulatory region-E6 promoter activity in undifferentiated primary human keratinocytes.

Authors:  W Zhao; F Noya; W Y Chen; T M Townes; L T Chow; T R Broker
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  Transgenic mouse model expressing tdTomato under involucrin promoter as a tool for analysis of epidermal differentiation and wound healing.

Authors:  Petr Kasparek; Pavel Krenek; Halka Buryova; Sarka Suchanova; Inken Maria Beck; Radislav Sedlacek
Journal:  Transgenic Res       Date:  2011-10-22       Impact factor: 2.788

5.  Restricted cytokine production from mouse peritoneal macrophages in culture in spite of extensive uptake of plasmid DNA.

Authors:  Kei Yasuda; Hiroki Kawano; Ikuko Yamane; Yoshiyuki Ogawa; Takaharu Yoshinaga; Makiya Nishikawa; Yoshinobu Takakura
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

6.  The SLE transcriptome exhibits evidence of chronic endotoxin exposure and has widespread dysregulation of non-coding and coding RNAs.

Authors:  Lihua Shi; Zhe Zhang; Angela M Yu; Wei Wang; Zhi Wei; Ehtisham Akhter; Kelly Maurer; Patrícia Costa Reis; Li Song; Michelle Petri; Kathleen E Sullivan
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

7.  Luciferase Expression Allows Bioluminescence Imaging But Imposes Limitations on the Orthotopic Mouse (4T1) Model of Breast Cancer.

Authors:  V P Baklaushev; A Kilpeläinen; S Petkov; M A Abakumov; N F Grinenko; G M Yusubalieva; A A Latanova; I L Gubskiy; F G Zabozlaev; E S Starodubova; T O Abakumova; M G Isaguliants; V P Chekhonin
Journal:  Sci Rep       Date:  2017-08-10       Impact factor: 4.379

8.  Prolonged gene expression in mouse lung endothelial cells following transfection with Epstein-Barr virus-based episomal plasmid.

Authors:  J Zhang; A Wilson; S Alber; Z Ma; Z-L Tang; E Satoh; O Mazda; S Watkins; L Huang; B Pitt; S Li
Journal:  Gene Ther       Date:  2003-05       Impact factor: 5.250

9.  Limited expression of non-integrating CpG-free plasmid is associated with increased nucleosome enrichment.

Authors:  Omar Habib; Rozita Mohd Sakri; Nadiah Ghazalli; De-Ming Chau; King-Hwa Ling; Syahril Abdullah
Journal:  PLoS One       Date:  2020-12-21       Impact factor: 3.240

10.  Antiangiogenic gene therapy of cancer: recent developments.

Authors:  Anita Tandle; Dan G Blazer; Steven K Libutti
Journal:  J Transl Med       Date:  2004-06-25       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.